Account
Clarins India assigns digital duties to MindShift Interactive
MUMBAI: Following a multi agency pitch, MindShift Interactive agency wins the digital mandate for Clarins India, a French luxury cosmetics company, which manufactures prestige skincare, makeup and fragrances products. Clarins India is currently distributed and marketed through Intercraft Trading Private Limited.
The mandate for MindShift Interactive is to manage the brands social media and media buying across platforms. MindShift Interactive will work towards building Clarins positioning as a pioneer in the industry through enhancing relationships with existing and new consumer sets on platforms such as Facebook and Instagram. The varied products offered by Clarins shall be highlighted through engaging content and campaigns, with a focus on creating an engaging visual story through photo shoots and micro-videos.
Commenting on the win, MindShift Interactive CEO Zafar Rais added here, “We are excited to have Clarins on board; enhancing the portfolio of beauty brands we work with. MindShift has a history of successful, benchmark campaigns with other beauty brands over the past 5 years and we intend on leveraging our understanding to help Clarins reach out to their target audience in a unique manner.”
Speaking on the occasion, Clarins India brand manager Bhakti Avalaskar Bhatt said, “Getting MindShift onboard was a decision to help us take our digital presence to the next level and reach out to our audiences in an interesting manner. MindShift’s expertise and understanding of our sector and their innovative approach towards story telling made them an easy decision as partners. We look forward to creating some waves within digital, locally and internationally.”
Account
BigTrunk Communications wins digital mandate for Soframycin
MUMBAI: BigTrunk Communications, an integrated digital marketing agency known for driving brand transformations across industries, has been awarded the digital marketing mandate for Soframycin, one of India’s most trusted antiseptic cream brands from the EncubeEthicals portfolio. With this collaboration, Soframycin makes its debut into the digital space, aiming to amplify its presence across India through compelling social media narratives and data-led campaigns. BigTrunk will lead the brand’s digital strategy and execution, with a focus on connecting Soframycin’s legacy of trust with today’s health-conscious and digitally engaged audience.
Soframycin has been a household name for generations, widely recognized for its efficacy in treating cuts, burns, and wounds. Backed by the scientific rigor and pharmaceutical expertise of EncubeEthicals, a pharmaceutical powerhouse since 1998, the brand benefits from the expertise of over 1,400 professionals, including more than 200 R&D specialists and a robust team of quality experts. With a presence in over 50 countries, Encube’s commitment to excellence in topical formulations adds deep credibility to Soframycin’s legacy. Now, as the brand enters the digital space, BigTrunk Communications will lead the charge in reimagining Soframycin’s story—creating modern, relatable digital experiences that stay true to its heritage.
“As we take Soframycin into its next chapter of growth, embracing digital media is not just a strategy but a necessity. We wanted a partner who could translate our scientific credibility into engaging, relatable content for today’s audience,” said Soframycin vice president – marketing, Ajay Rawal. “BigTrunk’s deep understanding of healthcare communications and digital behavior makes them the ideal partner to build meaningful narratives around wound care, trust, and wellbeing.”
“Soframycin is more than a product—it’s a legacy deeply rooted in care and science,” added BigTrunk Communications founder & managing director Bharat Subramaniam. “We’re excited to take on this responsibility of guiding a heritage brand into the digital world. Our focus will be on creating contextual storytelling and purpose-driven campaigns that bring Soframycin closer to Indian families, both old and new.”








